# Clinical trials recruiting in Florida: 4,183 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 4,183 trials recruiting or not yet recruiting with a site in Florida, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Florida: 4,183 rows for $121.83, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 98 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/florida

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 4,183
- Recruiting or not yet: 4,183
- Read on: November 19, 2026

## Trials

The 25 newest of 4,183, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947082 | An Adaptive Parent-mediated Intervention to Improve Outcomes for Autistic Children | Florida International University | Not applicable | Not yet recruiting | Autism | 680 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947082) |
| November 18, 2026 | NCT07946575 | A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy... | Trevi Therapeutics | Phase 1 | Recruiting | Healthy Participants | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946575) |
| November 18, 2026 | NCT07946237 | Optimizing Cough Rehabilitation Through Combined Cough Skill Training and Transcutaneous Spinal Cord Stimulation | University of Florida | Not applicable | Not yet recruiting | Healthy Adult, Rehabilitation Exercise, Electric Stimulation Therapy, Cough Peak Flow, Ventilatory Function | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946237) |
| November 18, 2026 | NCT07946068 | Aleniglipron Renal Impairment Study | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Phase 1 | Not yet recruiting | Renal Impairment, Severe Renal Impairment | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946068) |
| November 17, 2026 | NCT07941609 | A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLC | AstraZeneca | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941609) |
| November 17, 2026 | NCT07940738 | Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCy | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 | Recruiting | Hematologic Malignancy | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940738) |
| November 16, 2026 | NCT07938320 | Vuse Pro Puffing Topography Study in Adult Smokers | RAI Services Company | Not applicable | Recruiting | Smoking, Tobacco | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938320) |
| November 16, 2026 | NCT07937423 | DYNAMIC Pilot Optimization Trial | H. Lee Moffitt Cancer Center and Research Institute | Not applicable | Not yet recruiting | Advanced Cancer, Metastatic Cancer, Cancer Survivorship | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937423) |
| November 13, 2026 | NCT07936266 | Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R... | Sponsor not shown (see the record) | Phase 1 | Recruiting | B-cell Acute Lymphoblastic Leukemia (B-ALL) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936266) |
| November 13, 2026 | NCT07935889 | Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 Trial | Mayo Clinic | Phase 3 | Recruiting | Glioblastoma, IDH-Wildtype | 292 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935889) |
| November 13, 2026 | NCT07934680 | Mental Health Link for Veterans Referred to Mental Health Services | VA Office of Research and Development | Not applicable | Not yet recruiting | Depression | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934680) |
| November 12, 2026 | NCT07934303 | Study of NBIB-223 Gene Therapy in Friedreich's Ataxia (FACET) | Neurocrine Biosciences | Phase 1 | Not yet recruiting | Friedreich's Ataxia | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934303) |
| November 12, 2026 | NCT07933848 | A Study to Learn About the Study Medicine Called Prifetrastat in People With Renal Impairment | Pfizer | Phase 1 | Not yet recruiting | Renal Impairment, Healthy Adults | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933848) |
| November 12, 2026 | NCT07933393 | Lifestyle Strategies to Preserve Muscle and Reduce Cardiovascular Risk in Adults With Obesity Using GLP-1 Receptor Agonists | University of Florida | Not applicable | Not yet recruiting | Obesity & Overweight | 670 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933393) |
| November 12, 2026 | NCT07932704 | Press-Fit vs Loose-Fit Radial Head Arthroplasty | AdventHealth | Not applicable | Recruiting | Radial Head Fractures, Elbow Fractures, Elbow Dislocation, Elbow Injuries and Disorders | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932704) |
| November 12, 2026 | NCT07931703 | Safety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE) | Gedeon Richter Plc. | Phase 2 | Not yet recruiting | Social Anxiety Disorder | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931703) |
| November 12, 2026 | NCT07931664 | Evaluating Photodynamic Therapy Used to Treat Cutaneous Squamous Cell Carcinoma in Situ (isSCC) on the Face, Upper Extremities & Trunk. | The Center for Clinical and Cosmetic Research | Phase 2 | Recruiting | Cutaneous Squamous Cell Carcinoma in Situ, Facial Cutaneous Squamous Cell Carcinoma in Situ, Cutaneous Squamous Cell... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931664) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 12, 2026 | NCT07931495 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931495) |
| November 10, 2026 | NCT07930182 | Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 | Recruiting | Melanoma | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930182) |
| November 10, 2026 | NCT07929844 | Safety and Efficacy Study of SKX-16 in Participants With Mild to Moderate Distal Subungual Onychomycosis | SATO Pharmaceutical Co., Ltd. | Phase 2 | Not yet recruiting | Onychomycosis of Toenails | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929844) |
| November 10, 2026 | NCT07929792 | An Early Feasibility Study of a Robotically Implanted Brain-Computer Interface for Neural Control of External Devices in Spinal Cord... | Neuralink Corp | Not applicable | Recruiting | Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Chronic Ischemic Stroke, Tetraplegia/Tetraparesis | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929792) |
| November 10, 2026 | NCT07929701 | High-Intensity Functional Training vs. Moderate-Intensity Continuous Training in Cardiovascular Disease Patients | University of Miami | Not applicable | Not yet recruiting | Cardiovascular Disease (CVD) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929701) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of Miami | Miami | 295 |
| Moffitt Cancer Center | Tampa | 294 |
| University of Florida | Gainesville | 213 |
| Mayo Clinic in Florida | Jacksonville | 167 |
| University of South Florida | Tampa | 117 |
| University of Miami Miller School of Medicine-Sylvester Cancer Center | Miami | 75 |
| Tampa General Hospital | Tampa | 71 |
| Mayo Clinic Florida | Jacksonville | 69 |
| AdventHealth Orlando | Orlando | 68 |
| Florida Cancer Specialists | Sarasota | 63 |
| Johns Hopkins All Children's Hospital | St. Petersburg | 62 |
| Mayo Clinic | Jacksonville | 62 |
| Nicklaus Children's Hospital | Miami | 56 |
| UF Health Cancer Institute - Gainesville | Gainesville | 53 |
| Mayo Clinic Jacksonville | Jacksonville | 47 |
| UM Sylvester Comprehensive Cancer Center at Deerfield Beach | Deerfield Beach | 46 |
| Orlando Health Cancer Institute | Orlando | 45 |
| UM Sylvester Comprehensive Cancer Center at Coral Gables | Coral Gables | 45 |
| Miami Cancer Institute | Miami | 44 |
| UM Sylvester Comprehensive Cancer Center at Plantation | Plantation | 44 |
| Holy Cross Hospital | Fort Lauderdale | 43 |
| Mount Sinai Medical Center | Miami Beach | 42 |
| Cleveland Clinic Florida | Weston | 41 |
| Memorial Regional Hospital/Joe DiMaggio Children's Hospital | Hollywood | 39 |
| Saint Joseph's Hospital/Children's Hospital-Tampa | Tampa | 39 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 20 |
| Phase 1 | 475 |
| Phase 1/2 | 323 |
| Phase 2 | 787 |
| Phase 2/3 | 108 |
| Phase 3 | 920 |
| Phase 4 | 121 |
| Not applicable | 863 |
| Observational | 566 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 179 |
| Breast Neoplasms | 164 |
| Neoplasms | 137 |
| Colorectal Neoplasms | 108 |
| Prostatic Neoplasms | 106 |
| Neoplasm Metastasis | 102 |
| Obesity | 97 |
| Lung Neoplasms | 85 |
| Ovarian Neoplasms | 80 |
| Endometrial Neoplasms | 74 |
| Overweight | 68 |
| Pancreatic Neoplasms | 66 |
| Multiple Myeloma | 62 |
| Diabetes Mellitus, Type 2 | 60 |
| Recurrence | 60 |
| Leukemia, Myeloid, Acute | 60 |
| Squamous Cell Carcinoma of Head and Neck | 58 |
| Melanoma | 58 |
| Alzheimer Disease | 57 |
| Heart Failure | 56 |
| Triple Negative Breast Neoplasms | 48 |
| Depression | 45 |
| Stomach Neoplasms | 45 |
| Cardiovascular Diseases | 41 |
| Small Cell Lung Carcinoma | 40 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Florida | 175 |
| University of Miami | 157 |
| Mayo Clinic | 148 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 95 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 95 |
| H. Lee Moffitt Cancer Center and Research Institute | 76 |
| National Cancer Institute (NCI) | 74 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 63 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 62 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 52 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 51 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 48 |
| University of South Florida | 47 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 44 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 43 |
| Florida State University | 41 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 35 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 34 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 34 |
| University of Central Florida | 34 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 34 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 31 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 28 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 28 |
| VA Office of Research and Development | 27 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Florida

- [Business consulting firms in Florida, United States](https://specstream.ai/data/businesses/business-consulting-firms/florida-united-states)
- [Customs brokers in Florida, United States](https://specstream.ai/data/businesses/customs-brokers/florida-united-states)
- [Fertility clinics in Florida, United States](https://specstream.ai/data/businesses/fertility-clinics/florida-united-states)
- [Immigration law firms in Florida, United States](https://specstream.ai/data/businesses/immigration-law-firms/florida-united-states)
- [Medical service organizations in Florida, United States](https://specstream.ai/data/businesses/medical-service-organizations/florida-united-states)
- [Pizza restaurants in Florida, United States](https://specstream.ai/data/businesses/pizza-restaurants/florida-united-states)
